alternate-day fasting
Selected indexed studies
- Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity. (Cell Metab, 2023) [PMID:36868222]
- Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial. (Cell Metab, 2023) [PMID:36549296]
- A meta-analysis comparing the effectiveness of alternate day fasting, the 5:2 diet, and time-restricted eating for weight loss. (Obesity (Silver Spring), 2023) [PMID:36349432]
_Worker-drafted node — pending editorial review._
Connections
alternate-day fasting protects against
alternate-day fasting helps
Sources
- Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials. (2025) pubmed
- Sustained alternate-day fasting potentiates doxorubicin cardiotoxicity. (2023) pubmed
- Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial. (2023) pubmed
- A meta-analysis comparing the effectiveness of alternate day fasting, the 5:2 diet, and time-restricted eating for weight loss. (2023) pubmed
- Alternate Day Fasting Improves Physiological and Molecular Markers of Aging in Healthy, Non-obese Humans. (2019) pubmed
- Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection Among Metabolically Healthy Obese Adults: A Randomized Clinical Trial. (2017) pubmed
- Intermittent Fasting and Metabolic Health. (2022) pubmed
- Effect of a ketogenic diet, time-restricted eating, or alternate-day fasting on weight loss in adults with obesity: a randomized clinical trial. (2025) pubmed
- Alternate day fasting on subjective feelings of appetite and body weight for adults with overweight or obesity: a systematic review. (2022) pubmed
- Alternate day fasting aggravates atherosclerosis through the suppression of hepatic ATF3 in Apoe(-/-) mice. (2024) pubmed